Headlines

Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) Presented during Presidential Plenary Clinical Session of The Liver Meeting® 2018
November 12, 2018

Madrigal Pharmaceuticals Reports 2018 Third Quarter
November 6, 2018

Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
August 7, 2018

Press Release History